Y Intercept (Hong Kong) LTD Catalyst Pharmaceuticals, Inc. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $349,266 - $402,560	23,792 Added 145.23%	40,174 $622,000
Q1 2024 May 10, 2024	BUY	$13.18 - $17.11 $63,527 - $82,470	4,820 Added 41.69%	16,382 $261,000
Q4 2023 Feb 13, 2024	SELL	$11.78 - $17.29 $542,021 - $795,547	-46,012 Reduced 79.92%	11,562 $194,000
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $673,040 - $864,761	57,574 New	57,574 $673,000
Q2 2022 Aug 08, 2022	BUY	$6.23 - $8.57 $115,647 - $159,084	18,563 New	18,563 $130,000

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.